±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø Á¦15Â÷ °í¾ç.ÆÄÁÖ.±èÆ÷½ÃÀÇ»çȸ Çмú´ëȸ : 2019-10-12±³À°ÀÏÀÚ : 2019-10-12
±³À°Àå¼Ò : ±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø ´ë°´ç(ÁöÇÏ1Ãþ)
±³À°ÁÖÁ¦ :
Á¦15Â÷ °í¾ç.ÆÄÁÖ.±èÆ÷½ÃÀÇ»çȸ Çмú´ëȸÁÖÃÖ±â°ü : °æ±âµµÀÇ»çȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : °í¾ç½ÃÀÇ»çȸ
´ã´çÀÚ : ¹è¿µ¼±
¿¬¶ôó : 031-908-0028
À̸ÞÀÏ :
kma9080028@daum.net ±³À°Á¾·ù : ³»°ú, Á¤½Å°Ç°ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í °í¾ç.ÆÄÁÖ.±èÆ÷½ÃÀÇ»çȸ 2019³â ½Ãȸºñ ¹Ì³³È¸¿ø ¹× ŸÁö¿ª ȸ¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-12 ´ë°´ç 15:30~16:10 SGLT2 Inhibitors and CV Disease:
Advances in reducing cardiovascular risk
in the management of T2DM ÃÖ¿µÁÖ(Çã³»°úÀÇ¿ø)
±³À°½Ã°£ 10-12 ´ë°´ç 16:10~16:50 õ½ÄÀÇ Áø´Ü ¹× Ä¡·á ±è»óÈÆ(¼¿ïÀ»Áöº´¿ø)
±³À°½Ã°£ 10-12 ´ë°´ç 16:50~17:30 Flavoid ÀÇ ´Ù¾çÇÑ ÀÓ»óÀû È°¿ë ¾çµ¿ÈÆ(û´ã¹Ù·ÒŬ¸®´Ð)
±³À°½Ã°£ 10-12 ´ë°´ç 17:30~18:10 ÀÎÁö±â´ÉÀúÇÏ »ç·ÊÀÇ ´Ü°èº° Ä¡·á Àü·« ÀÌ»óÇö(±¹¹Î°Ç°º¸ÇèÀϻ꺴¿ø)
±³À°½Ã°£ 10-12 ´ë°´ç 18:10~18:50 1Â÷ Áø·á¿¡¼ Àν¶¸° Ä¡·áÀÇ ½ÃÀÛ°ú °ü¸® ¼Û¿µµæ(¼Û¿µµæ¿£µµ³»°úÀÇ¿ø)
±³À°½Ã°£ 10-12 ´ë°´ç 18:50~19:30 Triglyceride / LDL-C and Beyond ÇѱâÈÆ(¼¿ï¾Æ»êº´¿ø)